Skip to main content

Peer Review reports

From: The differential anti-tumour effects of zoledronic acid in breast cancer – evidence for a role of the activin signaling pathway

Original Submission
29 Sep 2014 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
2 Feb 2015 Editorially accepted
14 Feb 2015 Article published 10.1186/s12885-015-1066-7

You can find further information about peer review here.

Back to article page